Nanosphere Health Sciences Inc
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences … Read more
Market Cap & Net Worth: Nanosphere Health Sciences Inc (NSHSF)
Nanosphere Health Sciences Inc (PINK:NSHSF) has a market capitalization of $584.66K ($584.66K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #37935 globally and #12354 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nanosphere Health Sciences Inc's stock price $0.06 by its total outstanding shares 10275205 (10.28 Million).
Nanosphere Health Sciences Inc Market Cap History: 2015 to 2025
Nanosphere Health Sciences Inc's market capitalization history from 2015 to 2025. Data shows change from $1.70 Million to $584.66K (-8.55% CAGR).
Nanosphere Health Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nanosphere Health Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
-1.60x
Nanosphere Health Sciences Inc's market cap is -1.60 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.70 Million | $15.32K | -$133.62K | 111.17x | N/A |
| 2016 | $2.69 Million | $41.20K | -$614.68K | 65.34x | N/A |
| 2017 | $4.88 Million | $47.94K | -$9.91 Million | 101.73x | N/A |
| 2018 | $1.70 Million | $37.88K | -$4.51 Million | 44.76x | N/A |
| 2019 | $436.70K | $218.03K | -$3.47 Million | 2.00x | N/A |
| 2020 | $82.20K | $-51.23K | -$591.22K | -1.60x | N/A |
Competitor Companies of NSHSF by Market Capitalization
Companies near Nanosphere Health Sciences Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Nanosphere Health Sciences Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Nanosphere Health Sciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Nanosphere Health Sciences Inc's market cap moved from $1.70 Million to $ 584.66K, with a yearly change of -8.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $584.66K | +1397.37% |
| 2024 | $39.05K | +52.00% |
| 2023 | $25.69K | -77.27% |
| 2022 | $113.03K | -94.54% |
| 2021 | $2.07 Million | +2416.25% |
| 2020 | $82.20K | -81.18% |
| 2019 | $436.70K | -74.24% |
| 2018 | $1.70 Million | -65.23% |
| 2017 | $4.88 Million | +81.15% |
| 2016 | $2.69 Million | +58.02% |
| 2015 | $1.70 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nanosphere Health Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $584.66K USD |
| MoneyControl | $584.66K USD |
| MarketWatch | $584.66K USD |
| marketcap.company | $584.66K USD |
| Reuters | $584.66K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.